Combination therapies

Anyone have any experience with this clinical trial? If my PSA continues to increase my doctor is interested in my signing up for this....

Is anyone taking part in or have experience with this clinical trial? Scarlino asked about this 4 months ago and although he received several...

youtu.be/qTTB0JRXr2I youtu.be/p3IzC6Da8M8 ASH 2017...

Fantastic job by our friend and CLL patient Deborah Sims, interviewing Professor Peter Hillmen at the American Society of Hamatology Conferen...

I met someone this weekend who told me about a friend of his who had a radical prostatectomy in 1990. It didn't do the job and he soon had ra...

This week I'm posting an interview on our nonprofit’s website cllsociety.org with Dr. John Seymour from the Peter MacCallum Cancer Cen...

Male 62y, 7.5 years since diagnosis, last wbc at 60k which was 20k higher than about 18 months previously. Lymph node swellings in neck and s...

In this next clip Dr Manos Nikolousis discusses treating AML patients in a more effective way, studying genetic profiles to match patients to...

Just saw this article. I don't think it says anything that we don't know already, i.e., more aggressive combination therapies are significant...

I thought this was interesting and worth sharing: Role of PARP Inhibitors Clarified in Prostate Cancer Ariela Katz Published Online: May 22,2...

Dear Friends and Supporters of the CLL Society, On July 2nd the CLL Society website surpassed 1 million page-views. facebook.com/...

New cell study below. -Patrick ncbi.nlm.nih.gov/pubmed/281... Front Biosci ( Elite Ed )....

Today in the 2016 Conference Coverage section of the CLL Society website, we’ve posted an interview with Dr. Michael Hallek about the unmet n...

Was just reading a health magazine and they had interviewed very respectful endo. He supported all type of treatments for hypothyroidism....

•Thomas Kipps & William Weirda did excellent presentations on the CLL microenvironment & the search for therapeutic treatments to target that...

Friends, In this audio post on my blog, ( bkoffman.blogspot.com ) Dr. O'Brien gives some very informed speculation on what combination...

" : : " The randomized controlled trial is planned to enroll approximately 330 patients, who will receive ublituximab plus ibrutinib or ibrut...

Andrew Schorr interviews Dr. Jeff Sharman, medical director of hematology research at The US Oncology Network, exploring the multitude of new...

"-Carboline Alkaloid–Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells Debra L. Bemis, PhD, J...

Patients with unresectable, or inoperable, lung cancer are often given a dismal prognosis, with low rates of survival beyond a few years. Res...